{"id":"NCT00198107","sponsor":"Indiana University","briefTitle":"Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism","officialTitle":"Novel Pharmacological Strategies in Autism","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-09","primaryCompletion":"2011-09","completion":"2011-09","firstPosted":"2005-09-20","resultsPosted":"2019-03-29","lastUpdate":"2019-04-09"},"enrollment":81,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Autistic Disorder"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":["Abilify"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"D-cycloserine","otherNames":[]}],"arms":[{"label":"1 Placebo","type":"PLACEBO_COMPARATOR"},{"label":"2 Aripiprazole","type":"ACTIVE_COMPARATOR"},{"label":"3 Aripiprazole + D-cycloserine","type":"ACTIVE_COMPARATOR"}],"summary":"This study will determine the effectiveness of aripiprazole and D-Cycloserine in treating symptoms associated with autism in children.","primaryOutcome":{"measure":"Mean Post-baseline Aberrant Behavior Checklist Irritability Score, Parent Report, Double-blind Phase","timeFrame":"Weeks 1, 2, 3, 4, 6, and 8","effectByArm":[{"arm":"1 Placebo","deltaMin":25.5,"sd":null},{"arm":"2 Aripiprazole","deltaMin":18.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["37811711"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":["Tiredness/fatigue","Nasal congestion or Cold","Appetite increase","Vomiting","Appetite decrease"]}}